Mesenteric Fibromatosis with Involvement of the Gastrointestinal Tract. A GIST Simulator: A Study of 25 Cases

American Journal of Clinical Pathology

Volumn 121, Issue 1, 2004, Pages 93-98

  Rodriguez, Jaime A ^a   Guarda, Luis A ^a   Rosai, Juan ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Desmoid tumor; Gastrointestinal stromal tumor; Mesenteric fibromatosis

Indexed keywords

ABDOMINAL FIBROMATOSIS; ADOLESCENT; ADULT; AGED; ARTICLE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; DIAGNOSTIC ERROR; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESENTERY; PRIORITY JOURNAL;

EID: 0347130908     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/59VAH0KVF53WB633     Document Type: Article

References (29)

1. Burke AP, Sobin LH, Shekitka KM, et al. Intra-abdominal fibromatosis: a pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol. 1990;12:335-341.
2. Yannopoulos K, Stout AP. Primary solid tumors of the mesentery. Cancer. 1963;16:914-927.
3. Kim DH, Goldsmith HS, Quan SH, et al. Intra-abdominal desmoid tumor. Cancer. 1971;27:1041-1045.
4. Garner EJ, Richards RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet. 1953;5:139-147.
5. Gansar GF, Markowitz IP, Cerise EJ. Thirty years of experience with desmoid tumors at Charity Hospital. Am Surg. 1987;53:318-319.
6. Lim CL, Walker MJ, Mehta RR, et al. Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol. 1986;22:583-587.
7. Wilken N, Tattersall MH. Endocrine therapy for desmoid tumors. Cancer. 1991;68:1384-1388.
8. Li M, Cordon-Cardo C, Gerald W, et al. Desmoid fibromatosis is a clonal process. Hum Pathol. 1996;27:939-943.
9. Bridge JA, Sreekantiah C, Mouron B, et al. Clonal chromosomal abnormalities in desmoid tumors: implications for histopathogenesis. Cancer. 1992;69:430-436.
10. Middleton SB, Frayling IM, Phillips RK. Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer. 2000;82:827-832.
11. Alman BA, Li C, Pajerski ME, et al. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol. 1997;151:329-334.
12. Yantiss RK, Spiro IJ, Compton C, et al. Gastrointestinal stromal tumors versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis. Am J Surg Pathol. 2000;24:947-957.
13. Rosai J. GIST: an update. Int J Surg Pathol. 2003;11:177-186.
14. Weiss S, Goldblum JR, eds. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. St Louis, MO: Mosby; 2001:309-346.
15. Stout AP. Fibrosarcoma, the malignant tumor of fibroblasts. Cancer. 1948;1:30-63.
16. Kempson RL, Fletcher CDM, Evans HL, et al. Tumors of the Soft Tissues. Washington, DC: Armed Forces Institute of Pathology; 2001:78-81. Atlas of Tumor Pathology; Third series, Fascicle 30.
17. Al-Nafussi, Wong NACS. Intra-abdominal spindle cell lesions: a review and practical aids to diagnosis. Histopathology. 2001;38:387-402.
18. Stout AP. Juvenile fibromatoses. Cancer. 1954;7:953-978.
19. Plukker JT, van Oort I, Vermey A, et al. Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy. Br J Surg. 1995;82:510-514.
20. Ballo MT, Zagars GK, Pollack A, et al. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999;17:158-167.
21. Sportiello DJ, Hoogerland DL. A recurrent pelvic desmoid tumor successfully treated with tamoxifen. Cancer. 1991;67:1443-1446.
22. Lynch HT, Fitzgibbons R Jr, Chong S, et al. Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum. 1994;37:260-267.
23. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer. 1993;72:3244-3247.
24. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol. 2002;10:81-89.
25. Lucas DR, Al-Abbadi M, Tabaczka P, et al. c-Kit expression in desmoid fibromatosis: comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol. 2003;119:339-345.
26. Hornick JL, Fletcher CDM. Validating immunohistochemical staining for KIT (CD117) [editorial]. Am J Clin Pathol. 2003;119:325-327.
27. Montgomery E, Torberson MS, Kaushal M, et al. beta-Catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol. 2002;26:1296-1301.
28. Montgomery E, Lee JH, Abraham SC, et al. Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol. 2001;14:695-701.
29. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene. 1999;18:6615-6620.